Abstract
Presented at the ASHP Midyear Clinical Meeting. December 2023.
This project evaluated the appropriateness of interleukin (IL)-17 and IL-23 inhibitor usage within Parkview Health, in both inpatient and outpatient settings. This project set out to determine whether the inpatient use of intravenous (IV) iron replacement was justified and followed evidence-based guidelines.
Document Type
Poster
Publication Date
12-2023
Recommended Citation
Miller, Abby PharmD Candidate; Beckett, Robert D. PharmD, BCPS; Luty, Cole PharmD; and Gaul, Jamie PharmD, BCPS, "Evaluation of Intravenous Iron in the Inpatient Setting at a Large Health System." (2023). Parkview Pharmacy Department. 86.
https://researchrepository.parkviewhealth.org/pharma/86